Prediction: These 2 Under-the-Radar Stocks Could Beat the Market in the Next 5 Years

Every investor wants to outperform the market, but it's a challenging feat to achieve. That's why few manage to do it consistently over long periods. What's the best approach to take? Day trading is probably not it. Some research suggests that the overwhelming majority of day traders not only fail to beat the market, but actually lose money over the long run.A better strategy is to invest in quality stocks with attractive long-term prospects, and stick with them through thick and thin. Two companies worth considering in this regard are Axsome Therapeutics (NASDAQ: AXSM) and Exelixis (NASDAQ: EXEL). Here's why these two drugmakers could outperform broader equities in the next five years.Image source: Getty Images.Continue readingWeiter zum vollständigen Artikel bei MotleyFool Weiter zum vollständigen Artikel bei MotleyFool